Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors

• C. I. Edvard Smith,
• Jennifer R. Brown,
• Rula Zain,
• Rula Zain

Affiliations

C. I. Edvard Smith

Biomolecular and Cellular Medicine, Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet (KI), Huddinge, Sweden

Jennifer R. Brown

Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, MA, United States

Rula Zain

Biomolecular and Cellular Medicine, Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet (KI), Huddinge, Sweden

Rula Zain

Department of Clinical Genetics, Center for Rare Diseases, Karolinska University Hospital, Stockholm, Sweden